11 min read
Monthly FDA Guidance and Regulatory News Review - September 2026
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.
Learn More →
Rare disease trials are as rewarding as they are challenging. However, with more than 350 million rare disease sufferers worldwide today, the urgency for more treatments is paramount.
At Veristat, we're passionate and work tirelessly to learn and become experts in every unique and rare disease indication we work in. To date, we've worked on more than 300 clinical projects and have prepared more than 35 regulatory submissions for rare disease therapies.
We have a wide range of rare disease clinical experience, from trial design to patient recruitment and site engagement to submission. We would love the opportunity to help you with your next rare disease trial.
To speak with our experts at the World Orphan Drug Congress, send us a meeting request in the event App or fill out the form on the right. Find out how we can help you advance your next rare disease clinical trial, program or regulatory strategy to successful outcomes.
Veristat can help you overcome the most complex challenges of conducting rare and ultra-rare disease research across a breadth of therapeutic areas - Contact us or explore more of our rare disease resources:
11 min read
Oct 21, 2026 Veristat Blog
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
8 min read
Sep 21, 2026 Veristat Blog
This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...